Elizabeth A Maher - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Elizabeth A Maher

Showing results (51-60 of 54) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 54 results.

The Lancet. Gastroenterology & Hepatology|July 14, 2019

Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 studyMaeve A Lowery, Howard A Burris, Filip Janku, et al.

Neuro-Oncology|February 15, 2020

Glycine by MR spectroscopy is an imaging biomarker of glioma aggressivenessVivek Tiwari, Elena V Daoud, Kimmo J Hatanpaa, et al.

The New England Journal of Medicine|June 5, 2023

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade GliomaIngo K Mellinghoff, Martin J van den Bent, Deborah T Blumenthal, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006

Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, et al.

Pageof 6

Search research articles

Showing results (51-60 of 54) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 54 results.

The Lancet. Gastroenterology & Hepatology|July 14, 2019

Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 studyMaeve A Lowery, Howard A Burris, Filip Janku, et al.

Neuro-Oncology|February 15, 2020

Glycine by MR spectroscopy is an imaging biomarker of glioma aggressivenessVivek Tiwari, Elena V Daoud, Kimmo J Hatanpaa, et al.

The New England Journal of Medicine|June 5, 2023

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade GliomaIngo K Mellinghoff, Martin J van den Bent, Deborah T Blumenthal, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006

Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, et al.

Pageof 6